Company Planning Multi-Pronged Approach for QRX009 Including Several Investigator Led Clinical Studies in Key Indications. Company to Initiate ...

Filed Breakthrough Medicine Designation Application with Saudi FDA for QRX003 in Netherton Syndrome – Submitted Application to Japanese MHLW ...

Detailed price information for Quoin Pharmaceuticals Ltd ADR (QNRX-Q) from The Globe and Mail including charting and trades.

By M. Marin NASDAQ: QNRX READ THE FULL QNRX RESEARCH REPORT Targeting completing recruitment for Phase 3 trial by YE26, potentially filing NDA in 2027 for QRX003 as 1st approved treatment for NS Quoin ...

Clinical management of tuberous sclerosis complex (TSC) demands a coordinated, lifelong approach that addresses its multisystem manifestations. Early diagnosis often relies on genetic testing for TSC1 ...

More than 1 million people across the United States live with multiple sclerosis (MS), a disease that affects the brain, ...

From dry skin to allergies, here’s how to figure out what might be causing the itch.

Researchers have identified two compounds, K102 and K110, that could repair the nerve damage from multiple sclerosis. These drugs help regenerate the protective myelin sheath and balance immune ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› by Nancy Redd Sunscreen is personal, and the one you choose to slather on your ...

A series where we find out which products the professionals (who really know what they’re talking about) actually stand behind. Read more here. Building a skin-care routine for teens and tweens can ...

Sherri Gordon, CLC is a certified professional life coach, author, and journalist covering health and wellness, social issues, parenting, and mental health. She also has a certificate of completion ...

If you frequently experience facial redness, irritation and small bumps, you may be dealing with rosacea, a common skin condition that impacts more than 14 million people in the U.S. alone, according ...